Education
About Us
Working with TipRanks
Follow Us
Zomedica Corp (ZOMDF)
:ZOMDF
ZOMDF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.02 - $0.17
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.42M
Market Cap
$40.18M
Enterprise Value$23.92M
Total Cash (Recent Filing)$76.88M
Total Debt (Recent Filing)$2.08M
Price to Earnings (P/E)―
Beta0.88
Next Earnings
Aug 18, 2025EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding979,949,650
10 Day Avg. Volume1,024,612
30 Day Avg. Volume1,423,172
Financial Highlights & Ratios
PEG Ratio1.00
Price to Book (P/B)0.60
Price to Sales (P/S)0.00
P/FCF Ratio-12.58
Enterprise Value/Market Cap0.60
Enterprise Value/Revenue0.23
Enterprise Value/Gross Profit1.62
Enterprise Value/Ebitda-0.14
Forecast
1Y Price Target
$0.25Price Target Upside525.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Zomedica News
PremiumCompany Announcements
Zomedica Shareholders Approve Directors, Reject Compensation
PremiumCompany Announcements
Zomedica Reports Q1 2025 Growth Amid Strategic Expansion
PremiumCompany Announcements
Zomedica CFO Scott Jordan Resigns, Interim Replacement Named
PremiumCompany Announcements
Zomedica’s Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
Zomedica Achieves Record Revenue and Strategic Growth in 2024Bulls Say, Bears Say
Bulls Say
Financial PerformanceFinancial results show continued growth in an expanding market, meeting growth expectations both sequentially and in year-over-year comparisons.
Product InnovationZomedica has introduced several new assays for use with its TRUFORMA diagnostics platform, allowing veterinary practices to run tests without sending samples to an outside lab.
Sales GrowthThe TRUFORMA assays have been one of the sources of sales growth over the past year.
Bears Say
Price WeaknessAlthough Zomedica has made fundamental progress, the price weakness led to delisting and further price weakness.
Stock Price And DelistingThe closing price of Zomedica stock fell below $0.10 per share, forcing the delisting of ZOM shares.
Options Prices
Currently, No data available
---
Ownership Overview
2.36% Insiders
0.94% Mutual Funds
0.05% Other Institutional Investors
96.65% Public Companies and Individual Investors
ZOMDF FAQ
What was Zomedica Corp’s price range in the past 12 months?
Zomedica Corp lowest stock price was $0.01 and its highest was $0.17 in the past 12 months.
What is Zomedica Corp’s market cap?
Zomedica Corp’s market cap is $40.18M.
When is Zomedica Corp’s upcoming earnings report date?
Zomedica Corp’s upcoming earnings report date is Aug 18, 2025 which is in 57 days.
How were Zomedica Corp’s earnings last quarter?
Zomedica Corp released its earnings results on May 15, 2025. The company reported -$0.07 earnings per share for the quarter, missing the consensus estimate of -$0.007 by -$0.063.
Is Zomedica Corp overvalued?
According to Wall Street analysts Zomedica Corp’s price is currently Undervalued.
Does Zomedica Corp pay dividends?
Zomedica Corp does not currently pay dividends.
What is Zomedica Corp’s EPS estimate?
Zomedica Corp’s EPS estimate is >-0.01.
How many shares outstanding does Zomedica Corp have?
Zomedica Corp has 979,949,650 shares outstanding.
What happened to Zomedica Corp’s price movement after its last earnings report?
Zomedica Corp reported an EPS of -$0.07 in its last earnings report, missing expectations of -$0.007. Following the earnings report the stock price went down -16.667%.
Which hedge fund is a major shareholder of Zomedica Corp?
Currently, no hedge funds are holding shares in ZOMDF
Zomedica Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$0.25 (525.00% Upside)
$0.25 (525.00% Upside)
Blogger Sentiment
Bullish
ZOMDF Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 65.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $34.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▲ 0.3%
Last 30 Days ▼ 1.4%
Last 30 Days ▼ 1.4%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-70.92%
12-Months-Change
Fundamentals
Return on Equity
-55.79%
Trailing 12-Months
Asset Growth
-41.32%
Trailing 12-Months
Company Description
Zomedica Corp
Zomedica Pharmaceuticals Corp. operates as a development stage veterinary diagnostic and pharmaceutical company. It creates products for companion animals by focusing on the unmet needs of clinical veterinarians. The company was founded by Gerald L. Solensky, Jr. on January 7, 2013 and is headquartered in Ann Arbor, MI.
ZOMDF Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Zomedica's earnings call highlighted strong revenue growth, especially in the diagnostics segment, and successful international expansion. However, these positives were countered by significant challenges, including the delisting from the NYSE and an increased net loss. The company's strong liquidity position and product innovation are promising, but these are tempered by market and operational challenges.Read More>ZOMDF Stock 12 Month Forecast
Average Price Target
$0.25
▲(525.00%Upside)